neuropathic-pain | Media Room

Press Release Mar 4, 2021

Akelos Inc.'s Lead Compound Achieves Preclinical Safety Milestone

Press Release Feb 5, 2021

Akelos Inc.'s SAB Member Co-Authors Paper Validating HCN1 as a Therapeutic Target for the Treatment of Peripheral Neuropathic Pain

Press Release Nov 23, 2020

Akelos Inc.'s Lead Compound Achieves Preclinical Milestone

Press Release Sep 2, 2020

Dr. Steven R Fox Dentist to the World's Leaders Discusses Noxious Bad Breath Issues in a Fox 5 New York Interview

Dr. Fox discusses how in this Covid-19 environment volatile sulfur compounds as well as other foul smelling chemicals from our breath hit the mask and we smell our own bad breath in our mask.

Press Release Feb 3, 2020

Akelos Inc.'s PCT International Patent Application, Licensed From Cornell University, Has Published

Press Release Nov 18, 2019

Thomas G. Heffner, Ph.D., Former Pfizer Executive, Joins Akelos Inc. as a Strategic Advisor; Akelos Inc. is a Biotechnology Company Developing Opioid Alternatives

Press Release Nov 13, 2019

Dr. Steven Fox, Icon in Cosmetic Dentistry, Enhances Veneer Technique

Press Release Oct 28, 2019

Dr. Steven Fox, Renowned Cosmetic Dentist on Park Ave. in NYC, Improves Veneer Technique.

Press Release Oct 4, 2019

NIH Grant Awarded to Akelos Collaborator, Funds Work to Develop Non-Opioid Drugs for Neuropathic Pain

Press Release Jun 17, 2019

Roger Frechette, Ph.D., Joins Akelos Inc., as Director of Operations & Business Development

Press Release Feb 11, 2019

Akelos Inc. Files Third Patent Application to Develop New Treatment Option for Neuropathic Pain

Press Release Nov 5, 2018

Akelos Inc. Enters Collaboration to Develop Novel Treatment for Chronic and Neuropathic Pain

Press Release Apr 11, 2018

Xavant Technology Set to Disrupt Neuropathic Pain Treatment in the UK

Trial study at St. Thomas's Pain Management Centre shows dramatic effectiveness to treat chronic intractable pain